The results clearly showed that the expression levels of FIBCD1 in BC cell lines (MCF7, MDA-MB-231) were in glucose level-dependent manner: both FIBCD1 gene and protein expression levels under hyperglycemia conditions were higher than that in physiological glucose levels (Fig. 2H–K). This evidence concerns the gene FIBCD1 and breast cancer.